Burden of infections and preventive strategies in patients with relapsed/refractory multiple myeloma treated with bispecific antibodies - Top-Institutions - MDSpire

Infection Risks and Preventive Approaches in Relapsed/Refractory Multiple Myeloma Patients Undergoing Treatment with Bispecific Antibodies

  • By

  • Sorina-Nicoleta Badelita

  • Daniel-Nicolae Murariu

  • Andreea-Lacramioara Mohorea-Neata

  • Sinziana Barbu

  • Larisa Emilia Zidaru

  • Loredana Cirlan

  • Daniel Coriu

  • July 20, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    Tertiary University Hospital in Romania
    Tertiary University Hospital in Romania

    Cluj-Napoca, Romania

    Key Differentiators

    • Hematology

  • #4

    Peter MacCallum Cancer Centre
    Peter MacCallum Cancer Centre

    Melbourne, Australia

    Key Differentiators

    • Hematology
    • Oncology

  • #5

    Clinica Universidad de Navarra
    Clinica Universidad de Navarra

    Pamplona, Spain

    Key Differentiators

    • Hematology

Original Source(s)

Burden of infections and preventive strategies in patients with relapsed/refractory multiple myeloma treated with bispecific antibodies

  • by Sorina-Nicoleta Badelita, Daniel-Nicolae Murariu, Andreea-Lacramioara Mohorea-Neata, Sinziana Barbu, Larisa Emilia Zidaru, Loredana Cirlan, Daniel Coriu

  • July 20, 2026

Related Content

Loss of EMILIN-1/integrin axis drives microenvironmental reprogramming in gastric tumorigenesis

Treatment patterns and survival outcomes in elderly patients with intrahepatic cholangiocarcinoma: NCDB analysis

Oncogenic viruses and their role in oral cavity and oropharyngeal squamous cell carcinoma: a systematic review